Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides

Condition:   Mycosis Fungoides Intervention:   Drug: Brentuximab vedotin Sponsors:   M.D. Anderson Cancer Center;   Seagen Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials